India Pharmaceutical Manufacturing Market (2024 - 2030) Size, Share & Trends Analysis Report By Dosage Form (Tablets, Injectables), By Manufacturing Type (In-house, Contract), By Therapeutic Category (Endrocrinology, Cardiovascular), And Segment Forecasts

Market Segmentation

India Pharmaceutical Manufacturing Dosage Form Outlook (USD Million, 2018 - 2030)
- Tablets
- Capsules
  - Soft Gelatin Capsule
  - Hard Gelatin Capsule
  - Others
- Injectables
- Others
India Pharmaceutical Manufacturing Manufacturing Type Outlook (USD Million, 2018 - 2030)
- In-house Manufacturing
- Contract Manufacturing
India Pharmaceutical Manufacturing Therapeutic Category Outlook (USD Million, 2018 - 2030)
- Endocrinology
  - Canagliflozin
  - Empagliflozin
  - Semaglutide
  - Tirzepatide
  - Linagliptin
  - Alogliptin
  - Trelagliptin
  - Myo-inositol
- Cardiovascular
  - Treprostinil
  - Azilsartan Medoxomil
  - Azilsartan+Amlodipine
  - Amlodipine + Lisinopril
  - Sparsentan
  - Esaxerenone
- CNS
  - Cariprazine
  - Brexpiprazole
  - Lisdexamfetamine
  - Vortioxetine
  - Mirogabalin Besylate
  - Lasmiditan
  - Siponimod
- Analgesics
  - Ibuprofen+Famotidine
  - Upadacitinib
- Antacid
  - Pantoprazole
- Antibiotic
  - Doxycycline
  - Tedizolid
- Antifungal
  - Posaconazole
- Antiprotozoal
  - Nitazoxanide
- Hematology
  - Lenalidomide
  - Daprodustat
  - Roxadustat
  - Edoxaban
  - Avatrombopag
- Others
  - Linaclotide
  - Apremilast
  - Tegoprazan
  - Suvorexant
  - Vonoprazan
  - Rolapitant
  - Elagolix

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments